Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yuki Tsubakimoto"'
Autor:
Shigemi Nakajima, Hisayuki Inoue, Hiroshi Satake, Rena Chatani, Mariko Ohara, Yuki Tsubakimoto, Makoto Fujii, Hiroshi Hasegawa, Keiko Takahashi, Kiyoyuki Hayafuji, Yoshihide Fujiyama
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 2, Pp 210-222 (2022)
Background and Aims: Vonoprazan-based eradication therapies have a higher eradication rate than usual proton pump inhibitor (PPI)–based therapies in treating Helicobacter pylori infection. Should we use vonoprazan to treat patients who failed multi
Externí odkaz:
https://doaj.org/article/bbc624c707934c328f1879583326e396
Autor:
Yoshihide Fujiyama, Keiko Takahashi, Mariko Ohara, Makoto Fujii, Yuki Tsubakimoto, Hiroshi Hasegawa, Shigemi Nakajima, Hiroshi Satake, Hisayuki Inoue, Kiyoyuki Hayafuji, Rena Chatani
Publikováno v:
Gastro Hep Advances. 1:210-222
Background and Aims Vonoprazan-based eradication therapies have higher eradication rate than usual proton pump inhibitor (PPI)-based therapies in treating Helicobacter pylori infection. Should we use vonoprazan to treat patients who failed multiple e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab58bfff917de1b21d3f9d16af458120
https://doi.org/10.1016/j.gastha.2021.11.006
https://doi.org/10.1016/j.gastha.2021.11.006
Publikováno v:
Healthcare; Volume 10; Issue 4; Pages: 747
We evaluated the usefulness of two novel cholesterol-triglyceride subgroup (CTS) indices, CTSqlt and CTSqnt, that potentially reflect the metabolic status regarding risk of coronary heart disease (CHD) using a retrospective longitudinal study of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c217e872e427065508def7ae4be8bdf7